Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DRGEM is a South Korea-based public medical imaging company focused on diagnostic X-ray systems and related imaging software. Founded in 2003, the company develops, manufactures, and sells stationary radiography systems, mobile X-ray systems, portable X-ray systems, veterinary imaging products, generators, and imaging workflow software. Its installed and distributor footprint spans more than 120 countries, supported by a headquarters and R&D presence in Gwangmyeong and manufacturing operations in Gimcheon. In 2026, DRGEM expanded beyond X-ray into diagnostic ultrasound with the launch of the DS20 and DS30 systems, while also advancing AI-enabled low-dose imaging and C-arm development. The company appears to be a commercial-stage healthcare equipment manufacturer rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DRGEM.